Can chemoimmunotherapy in CLL treatment be replaced with novel agents?
An update on kinase inhibitors from EHA 2017
Conversations doctors must have with CLL patients
Next-generation BTK inhibitors and their value in CLL
Major breakthroughs in AL amyloidosis treatment from ASH 2017